Minimally invasive surgery plus deferoxamine for intracerebral hemorrhage
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if combining a minimally invasive surgical procedure with deferoxamine, a drug that helps remove extra iron, improves recovery for people with a type of brain bleed called intracerebral hemorrhage. It aims to see if this combination reduces damage and helps patients regain function better than standard care alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 80 years old
- You have a brain bleed (intracerebral hemorrhage) confirmed by a CT scan, with a clot size of at least 30 mL on first scan, or at least 25 mL on a later scan with no more than 5 mL growth
- Your stroke symptoms started within the last 24 hours and your NIHSS score is 6 or higher
- You had no major disability before the bleed (mRS 0-1)
- Your blood pressure is below 180 mm Hg for at least 6 hours before randomization
- You are willing to start treatment between 12 and 24 hours after your first CT scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
This trial looks at whether starting brain surgery within 8 hours after a type of stroke called intracerebral hemorrhage (bleeding in the brain) can improve outcomes. It’s for adults with a certain amount and location of bleeding and without common causes like an aneurysm or malformation.
This trial tests a minimally invasive surgery (soft channel drainage) to remove a large blood clot deep in the brain after a stroke. It is for people who can have the procedure within 48 hours of bleeding and whose consciousness is reduced but not completely gone.
This trial looks at how people recover after surgery for a brain bleed (intracerebral hemorrhage). It aims to find the best timing for treatment to improve recovery. If you have had a brain bleed and are eligible for surgery, you may be able to join.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.